Disclosures for "The Role of Intrapulmonary Shunt (IPS) in Embolic Stroke of Undetermined Source (ESUS)"
-
Ms. Houser has nothing to disclose.
-
Ms. Schleicher has nothing to disclose.
-
The institution of Bichum Ouyang has received research support from NIH.
-
-
Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.